These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 649553)

  • 21. Mutagenicity studies of R-amino salt, a metabolite of amaranth (FD & C Red NO. 2), in mouse lymphoma cells heterozygous at the thymidine kinase locus and in the rat dominant lethal test.
    Palmer KA; Sheu CW; Green S
    Food Cosmet Toxicol; 1979 Feb; 17(1):5-9. PubMed ID: 437613
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of chemical mutagens using a host-mediated assay (L5178Y) mutagenesis system.
    Fischer GA; Lee SY; Calabresi P
    Mutat Res; 1974 Dec; 26(6):501-11. PubMed ID: 4372529
    [No Abstract]   [Full Text] [Related]  

  • 23. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells.
    Clive D; Flamm WG; Machesko MR; Bernheim NJ
    Mutat Res; 1972 Sep; 16(7):77-87. PubMed ID: 5053587
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutagenicity of hycanthone in mammalian cells.
    Clive D; Flamm WG; Machesko MR
    Mutat Res; 1972 Feb; 14(2):262-4. PubMed ID: 5062703
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristics of spontaneous and induced thymidine and 5-iodo-2-deoxyuridine resistant clones of mouse lymphoma cells.
    Fox M; Anderson D
    Mutat Res; 1974 Oct; 25(1):89-105. PubMed ID: 4530153
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytogenetic evidence for hemizygosity at the thymidine kinase locus in P388 mouse lymphoma cells.
    Yasseen AA; McKenna PG
    Experientia; 1983 May; 39(5):532-4. PubMed ID: 6852181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a quantitative cytotoxicity assay using mouse lymphoma TK cells.
    Liu X; Zhang F; Rodeheaver D; Wright A; Tolliver C; Walker J; Rose R
    Toxicol In Vitro; 2017 Dec; 45(Pt 1):172-180. PubMed ID: 28887288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report--Plymouth, UK 2002.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Cifone M; Delongchamp R; Fellows M; Gollapudi B; Jenkinson P; Kirby P; Kirchner S; Muster W; Myhr B; O'Donovan M; Oliver J; Omori T; Ouldelhkim MC; Pant K; Preston R; Riach C; San R; Stankowski LF; Thakur A; Wakuri S; Yoshimura I;
    Mutat Res; 2003 Oct; 540(2):127-40. PubMed ID: 14550497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct assay of thymidine kinase bound to ion-exchange paper for dot spotting and enzyme blotting analysis.
    van den Berg KJ
    Anal Biochem; 1986 May; 155(1):149-54. PubMed ID: 3717551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An alternative linear trend analysis for assessing the results of the mouse lymphoma assay.
    Hou S; Sjögren N; Bolcsfoldi G
    Environ Mol Mutagen; 2012 Jan; 53(1):55-61. PubMed ID: 21976131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome sequencing of mouse lymphoma L5178Y-3.7.2C (TK
    McKinzie PB; Revollo JR
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():1-6. PubMed ID: 28137362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glial tumor cells deficient in thymidine kinase: isolation and characterization.
    Schimmer BP; Stevenson LF; ter Hofstede C; Cheung NH; Marks A
    Exp Cell Res; 1974 Jun; 86(2):425-8. PubMed ID: 4842353
    [No Abstract]   [Full Text] [Related]  

  • 33. Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report.
    Romain S; Spyratos F; Guirou O; Deytieux S; Chinot O; Martin PM
    Eur J Cancer; 1994; 30A(14):2163-5. PubMed ID: 7857717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature of thymidine kinase in the human-mouse hybrid cell.
    Migeon BR; Smith SW; Leddy CL
    Biochem Genet; 1969 Dec; 3(6):583-90. PubMed ID: 5369310
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay.
    Skopek TR; Liber HL; Penman BW; Thilly WG
    Biochem Biophys Res Commun; 1978 Sep; 84(2):411-6. PubMed ID: 214074
    [No Abstract]   [Full Text] [Related]  

  • 36. An efficient washing procedures for thymidine kinase assay.
    Litteria M; Popoff CG
    Neurochem Res; 1981 Aug; 6(8):931-4. PubMed ID: 7312102
    [No Abstract]   [Full Text] [Related]  

  • 37. Thymidine kinase heterozygous L5178Y mouse lymphoma forward mutational assay.
    Palmer K
    J Assoc Off Anal Chem; 1978 May; 61(3):609-11. PubMed ID: 649553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of thymidine kinase in L5178Y mouse lymphoma cells.
    Palmer KA; De Giovanni-Donnelly R
    Toxicol Ind Health; 1985 Nov; 1(3):1-12. PubMed ID: 3842549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence analysis of tka(-)-1 and tkb(+)-1 alleles in L5178Y tk+/- mouse-lymphoma cells and spontaneous tk-/- mutants.
    Liechty MC; Rauchfuss HS; Lugo MH; Hozier JC
    Mutat Res; 1993 Apr; 286(2):299-307. PubMed ID: 7681542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.